@article{f4b18ff3fa6946ed8b2382261a87d8c1,
title = "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study",
keywords = "Bisphosphonate, Fracture, Mortality risk, Osteoporosis, Prospective study, DELTA T-CELLS, SUBSEQUENT FRACTURE, BONE LOSS, OSTEOPOROTIC FRACTURE, ZOLEDRONIC ACID, HIP FRACTURE, WOMEN, MEN, PAMIDRONATE, EFFICACY",
author = "D. Bliuc and T. Tran and {van Geel}, T. and Adachi, {J. D.} and C. Berger and {van den Bergh}, J. and Eisman, {J. A.} and P. Geusens and D. Goltzman and Hanley, {D. A.} and Josse, {R. G.} and S. Kaiser and Kovacs, {C. S.} and L. Langsetmo and Prior, {J. C.} and T. Nguyen and Center, {J. R.} and {CaMOS Res Grp}",
year = "2019",
month = apr,
doi = "10.1007/s00198-018-4806-0",
language = "English",
volume = "30",
pages = "817--828",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer-Verlag London Ltd.",
number = "4",
}